Missing/wrong data?
Log in to edit
Rituximab is highly effective for pure red cell aplasia and post-transplant lymphoproliferative disorder after unrelated hematopoietic stem cell transplantation
scientific article published on July 6, 2012
Author/s
author: Grzegorz Helbig, Sławomira Kyrcz-Krzemień, Anna Kopińska
Work details
Publication date
July 6, 2012
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.